FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

4 Observations in SSM Health Care Inspection

FDA releases the FDA-483 with four observations from an inspection at Fenton, MO-based SSM St. Clare Health Center.

Medical Devices

Updated Safety Info on Endologix Grafts

FDA updates its 12/2020 safety communication on Endologixs AFX endovascular graft systems used in treating abdominal aortic aneurysms and the risks as...

Medical Devices

Mentor MemoryGel Boost Breast Implant OKd

FDA approves Mentors MemoryGel Boost Breast Implant for breast augmentation in women at least 22 years old, and for women of all ages undergoing breas...

Biologics

FDA Revises Janssen Vaccine Fact Sheets

FDA revises fact sheets for the Janssen Covid-19 vaccine to discuss the risk of immune thrombocytopenia during the 42 days after vaccination.

Medical Devices

FDA Extends Expiration on Covid Tests in Florida

FDA extends the expiration date on about one million unused Covid test kits in Florida.

Human Drugs

Dental Issues with Some Buprenorphine Use: FDA

FDA warns patients and providers about the potential for dental problems associated with dissolving buprenorphine products in the mouth to treat opioi...

Human Drugs

Mitsubishi Tanabe NDA for Oral ALS Drug

FDA accepts for priority review a Mitsubishi Tanabe Pharma America NDA for edaravone (MT-1186) for treating amyotrophic lateral sclerosis.

Human Drugs

CMS Questions FDA Aduhelm Approval: Analysis

Washington University in St. Louis law professor Rachel Sachs says a CMS restricted coverage determination for Biogens Aduhelm adds to questions about...

Human Drugs

Novartis Seeking EUA for Covid Therapeutic

Novartis and Molecular Partners say they plan to seek an FDA emergency use authorization after reporting results from the EMPATHY clinical trial that...

Human Drugs

Skinny Label Allowed Faster Generic Entry: Study

Harvard Medical School researchers say the use of skinny labeling in generic forms of Novartis Gleevec allowed the generics to enter the market before...